Direxion Daily S&P Biotech Bear 3X ETF
LABD
19 hedge funds and large institutions have $41.8M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
115% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $5.05M
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
19% more funds holding
Funds holding: 16 → 19 (+3)
2.72% less ownership
Funds ownership: 7.18% → 4.46% (-2.7%)
7% less capital invested
Capital invested by funds: $44.7M → $41.8M (-$2.91M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$45.1M |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
+$6.62M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
+$2.05M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$5.62M |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
-$5.49M |
| 3 |
Goldman Sachs
New York
|
-$2.14M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$234K |
| 5 |
GS
GTS Securities
New York
|
-$158K |
LABD Hedge Fund Activity: Q4 2023 in Review
19 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2023, worth a combined $41.8M — down 6.5% from $44.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LABD positions and 1 closed out — a net gain of 4 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was HRT Financial, adding an estimated $45.1M. The largest seller was Jane Street, exiting entirely with an estimated $5.62M sold.
- 19 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2023, up from 16 in Q3 2023.
- Funds reported $41.8M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2023, down 6.5% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2023 and 1 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2023 was HRT Financial, an estimated $45.1M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2023 was Jane Street, an estimated $5.62M sold.
Based on aggregated 13F filings for Q4 2023.